All Activities
Choose from the criteria below to find an activity that fits you best.
Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information ►
Featured Activity
Contemporary Evaluation and Management of Lung Cancer Targeted Therapies
Learn about treatment options, treatment failure, associated adverse effects and more.
Choose from the criteria below to find an activity that fits you best.
SHOW SEARCH
![]() |
![]() |
![]() |
|
SIDP Members login to SIDP to verify your membership, then follow the members only link to receive discounts ![]() |
![]() |
A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) |
This activity will review a recent infectious disease journal article and critically
evaluate study rationale and design, results, strengths/limitations of the research,
and applicability of findings to clinical practice. This activity will be repeated
on a quarterly basis with a focus on a different journal article and study design
each time.
An open-access journal article will be selected for the activity, and a step-by-step
discussion guide created by the faculty will be made accessible to participants. Participants
are invited to read the article and review a downloadable discussion guide (as home-study)
to consider faculty insights before completing an assessment for CE and/or BCIDP credit.
A Twitter chat will be scheduled approximately 2 weeks after activity launch to facilitate
additional discussion surrounding the selected article. Participation in the Twitter
chat is optional (i.e. not required for CE and/or BCIDP credit) but encouraged to
foster a thorough discussion of the article and key learning points.
The target audience for this activity includes pharmacists and board-certified infectious diseases pharmacists (BCIDPs) seeking to update their knowledge and skills related to contemporary infectious diseases literature review. At the completion of this activity, the participant will be able to:
Madeline King, PharmD, BCIDP
Assistant Professor of Clinical Pharmacy, Infectious Diseases
University of the Sciences, Philadelphia College of Pharmacy
Release Date: 02-03-2020
Expiration Date: 02-03-2023
BCIDP Expiration: 02-03-2021
This activity is jointly provided by ProCE, Inc. and the Society of
Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal
Activity Number 0221-9999-20-007-H01-P has been assigned to this home study, knowledge-based
activity. This activity is approved for 1.5 contact hour (0.15 CEU) in states that
recognize ACPE providers. Participants must complete the online post-test and activity
evaluation to receive pharmacy CE credit. No partial credit will be given. Statements
of completion will be issued online at www.ProCE.com, and proof of completion will
be posted in NABP CPE Monitor profiles.
The Society of Infectious Diseases Pharmacists (SIDP) is accredited
by the Board of Pharmacy Specialties (BPS) as a provider of board certified infectious
diseases pharmacist (BCIDP) credit. A BCIDP statement of credit will be issued online
upon successful completion of a post-test and online evaluation. The post-test must
be successfully completed in only one attempt. No partial credit will be given. BCIDP
accreditation begins 02/03/2020 for this activity and is available for one year from
this date.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Dr. King has served as a speaker for Tetraphase.
This activity is provided by ProCE, Inc. and SIDP.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.